An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease

被引：0

作者：

Shua-Haim, JR ^{[1
]}

Pass, MD ^{[1
]}

Patel, S ^{[1
]}

Lee, P ^{[1
]}

Patel, P ^{[1
]}

机构：

[1] Jersey Shore Univ Med Ctr, Neptune, NJ USA

来源：

NEUROBIOLOGY OF AGING | 2004年 / 25卷

关键词：

D O I：

10.1016/S0197-4580(04)80659-6

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：S196 / S196

页数：1

共 50 条

[1] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment for treatment of Alzheimer's disease
Shua-Haim, JR
Pass, M
INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 356 - 356
[2] An investigation into the safety, tolerability, and efficacy of high dose rivastigmine treatment in Alzheimer's disease.
Shua-Haim, JR
Pass, MD
Smith, J
Lee, PP
Patel, S
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S93 - S93
[3] Safety, tolerability and clinical impression of high dose rivastigmine treatment for patients with Alzheimer's disease (AD)
Shua-Haim, J
Patel, S
Smith, J
INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 232 - 233
[4] Investigation of safety, tolerability, and efficacy of high dose (15-17.5 mg/day) rivastigmine (exelon) treatment for Alzheimer's disease patients.
Pass, M
Shua-Haim, J
Patel, S
GERONTOLOGIST, 2003, 43 : 165 - 165
[5] Rivastigmine and Concomitant Memantine in Alzheimer's Disease: Safety and Tolerability
Safirstein, Beth
Meng, Xiangyi
Olin, Jason T.
CNS SPECTRUMS, 2010, 15 (09) : 594 - 598
[6] Safety, tolerability, and caregiver's impressions of combination therapy with rivastigmine and memantine for the treatment of Alzheimer's disease
Shua-Haim, JR
Pass, MD
Patel, S
Patel, S
Lee, P
Smith, J
NEUROBIOLOGY OF AGING, 2004, 25 : S205 - S205
[7] Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia
Darreh-Shori, Taher
Jelic, Vesna
EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) : 167 - 176
[8] Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer's disease in daily practice
Seibert, Johannes
Tracik, Ferenc
Articus, Konstantin
Spittler, Stefan
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 141 - 147
[9] Safety and tolerability of rivastigmine capsules plus memantine in patients with probable Alzheimer's disease
Brannan, Stephen
Koumaras, Barbara
Figiel, Gary
Farlow, Martin
ANNALS OF NEUROLOGY, 2008, 64 : S40 - S41
[10] Safety/Tolerability and Efficacy of Rivastigmine in Taiwanese Patients with Alzheimer's Disease A Prospective Post-Marketing Surveillance Study
Chiu, Pai-Yi
Dai, Dao-En
Hsu, Hai-Pei
Lee, Chao
Lin, Juei-Jueng
Kuo, Hung-Chou
Huang, Ying-Chih
Liu, Yung-Chang
Tsai, Ching-Piao
CLINICAL DRUG INVESTIGATION, 2009, 29 (11) : 729 - 738

← 1 2 3 4 5 →